Author Correction: Lipid management in patients with chronic kidney disease

Charles J Ferro¹, Patrick B Mark², Mehmet Kanbay³, Pantelis Sarafidis⁴, Gunnar H Heine⁵, Patrick Rossignol⁶, Ziad A Massy⁷, Francesca Mallamaci⁸, Jose M Valdivielso⁹, Jolanta Malyszko¹⁰, Marianne C Verhaar¹¹, Robert Ekart¹², Raymond Vanholder¹³, Gerard London¹⁴, Alberto Ortiz¹⁵, Carmine Zoccali⁸

Affiliations

¹ Department of Renal Medicine, University Hospitals Birmingham, Edgbaston, Birmingham, UK. charles.ferro@uhb.nhs.uk.
² Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
³ Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey.
⁴ Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁵ Saarland University Medical Center, Internal Medicine IV-Nephrology and Hypertension, Homburg, Germany.
⁶ Centre d'Investigation Clinique Plurithématique Pierre Drouin - INSERM CHU de Nancy, Nancy, France.
⁷ Hopital Ambroise Paré, Paris Ile de France Ouest (UVSQ) University, Paris, France.
⁸ CNR- IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases, Ospedali Riuniti, Italy.
⁹ Vascular and Renal Translational Research Group, UDETMA, REDINREN del ISCIII, IRBLleida, Lleida, Spain.
¹⁰ Department of Nephrology, Dialysis Therapy and Internal Medicine, Warsaw Medical University, Warsaw, Poland.
¹¹ Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
¹² Faculty of Medicine, Maribor University, Maribor, Slovenia.
¹³ Nephrology Section, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium.
¹⁴ Service de Néphrologie, Hôpital Manhès, Fleury Mérogis, France.
¹⁵ IIS- Fundacion Jimenez Diaz, School of Medicine, University Autonoma of Madrid, FRIAT and REDINREN, Madrid, Spain.

PMID: 30538326
DOI: 10.1038/s41581-018-0099-y

Published Erratum

Author Correction: Lipid management in patients with chronic kidney disease

Charles J Ferro et al. Nat Rev Nephrol. 2019 Feb.

. 2019 Feb;15(2):121.

doi: 10.1038/s41581-018-0099-y.

Authors

Affiliations

¹ Department of Renal Medicine, University Hospitals Birmingham, Edgbaston, Birmingham, UK. charles.ferro@uhb.nhs.uk.
² Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
³ Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey.
⁴ Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁵ Saarland University Medical Center, Internal Medicine IV-Nephrology and Hypertension, Homburg, Germany.
⁶ Centre d'Investigation Clinique Plurithématique Pierre Drouin - INSERM CHU de Nancy, Nancy, France.
⁷ Hopital Ambroise Paré, Paris Ile de France Ouest (UVSQ) University, Paris, France.
⁸ CNR- IFC, Clinical Epidemiology and Pathophysiology of Hypertension and Renal Diseases, Ospedali Riuniti, Italy.
⁹ Vascular and Renal Translational Research Group, UDETMA, REDINREN del ISCIII, IRBLleida, Lleida, Spain.
¹⁰ Department of Nephrology, Dialysis Therapy and Internal Medicine, Warsaw Medical University, Warsaw, Poland.
¹¹ Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
¹² Faculty of Medicine, Maribor University, Maribor, Slovenia.
¹³ Nephrology Section, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium.
¹⁴ Service de Néphrologie, Hôpital Manhès, Fleury Mérogis, France.
¹⁵ IIS- Fundacion Jimenez Diaz, School of Medicine, University Autonoma of Madrid, FRIAT and REDINREN, Madrid, Spain.

PMID: 30538326
DOI: 10.1038/s41581-018-0099-y

Abstract

In the acknowledgements section of this article as originally published, information on the authors' roles as EURECAm members is missing. The correct acknowledgement is as follows: "This Review was planned as part of the activity of the European Renal and Cardiovascular Medicine working (EURECAm) group and all authors are EURECAm members. A.O.'s work was supported by Spanish Government ISCIII FEDER funds (PI16/02057, ISCIII-RETIC REDinREN RD16/0009) and Community of Madrid (B2017/BMD-3686 CIFRA2-CM). P.R.'s work is supported by a public grant overseen by the French National Research Agency (ANR) as part of the second "Investissements d'Avenir" program FIGHT-HF (reference: ANR-15-RHU-0004) and by the French PIA project "Lorraine Université d'Excellence", reference ANR-15-IDEX-04-LUE." The omission has been corrected in the PDF and HTML versions of the article.

PubMed Disclaimer

Erratum for

Lipid management in patients with chronic kidney disease.
Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C. Ferro CJ, et al. Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Nat Rev Nephrol. 2018. PMID: 30361677 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Lipid management in patients with chronic kidney disease

Affiliations

Author Correction: Lipid management in patients with chronic kidney disease

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous